| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.985 | 8 | 6 | 1994 | 2019 | ||||||||
|
CD58 molecule | 0.584 | 0.769 | 0.25 |
|
disease | 0.500 | None | 1.000 | 6 | 3 | 2008 | 2019 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.500 | None | 1.000 | 5 | 5 | 2009 | 2020 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
disease | 0.500 | None | 0.970 | 4 | 1 | 1999 | 2019 | ||||||||
|
interleukin 7 receptor | 0.487 | 0.769 | 3.8E-07 |
|
disease | 0.500 | None | 0.982 | 3 | 2 | 2003 | 2019 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.500 | None | 0.958 | 1 | 1 | 2000 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 1 | 1 | 1992 | 2020 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.490 | None | 1.000 | 1 | 1 | 2009 | 2014 | ||||||||
|
kinesin family member 1B | 0.516 | 0.808 | 1.00 |
|
disease | 0.460 | None | 1.000 | 1 | 1 | 2008 | 2014 | ||||||||
|
Cbl proto-oncogene B | 0.691 | 0.423 | 1.00 |
|
disease | 0.440 | None | 0.800 | 2 | 1 | 2010 | 2017 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.430 | None | 1.000 | 1 | 1 | 2008 | 2017 | ||||||||
|
TNF superfamily member 14 | 0.529 | 0.769 | 5.2E-02 |
|
disease | 0.420 | None | 1.000 | 2 | 1 | 2011 | 2013 | ||||||||
|
CD6 molecule | 0.489 | 0.808 | 9.3E-05 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2009 | 2016 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.200 | None | 1.000 | 4 | 4 | 2004 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.884 | 2 | 2 | 1991 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.919 | 1 | 1 | 1978 | 2019 | ||||||||
|
cytochrome P450 family 27 subfamily B member 1 | 0.502 | 0.769 | 1.9E-07 |
|
disease | 0.200 | None | 0.905 | 1 | 1 | 2008 | 2019 | ||||||||
|
glypican 5 | 0.626 | 0.654 | 4.0E-10 |
|
disease | 0.170 | None | 1.000 | 1 | 1 | 2009 | 2014 | ||||||||
|
ecotropic viral integration site 5 | 0.743 | 0.346 | 2.0E-11 |
|
disease | 0.160 | None | 1.000 | 3 | 3 | 2008 | 2017 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.160 | None | 1.000 | 2 | 1 | 1999 | 2018 | ||||||||
|
ETS transcription factor ERG | 0.453 | 0.808 | 0.96 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2016 | 2019 | ||||||||
|
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase | 0.638 | 0.500 | 1.00 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2010 | 2013 | ||||||||
|
T cell activation RhoGTPase activating protein | 0.700 | 0.462 | 0.85 |
|
disease | 0.130 | None | 1.000 | 2 | 1 | 2011 | 2017 | ||||||||
|
Fc receptor like 3 | 0.612 | 0.769 | 6.0E-21 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2007 | 2016 | ||||||||
|
regulator of G protein signaling 1 | 0.653 | 0.731 | 0.78 |
|
disease | 0.130 | None | 0.750 | 1 | 1 | 2010 | 2016 |